<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.9.2 (http://www.squarespace.com/) on Thu, 11 Mar 2010 06:54:26 GMT--><feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><title>The Melanoma Blog</title><subtitle>The Melanoma Blog</subtitle><id>http://themelanomablog.com/blogs/</id><link rel="alternate" type="application/xhtml+xml" href="http://themelanomablog.com/blogs/"/><link rel="self" type="application/atom+xml" href="http://themelanomablog.com/blogs/atom.xml"/><updated>2009-08-12T21:34:31Z</updated><generator uri="http://www.squarespace.com/" version="Squarespace Site Server v5.9.2 (http://www.squarespace.com/)">Squarespace</generator><entry><title>NEW CLINICAL TRIAL OPEN</title><id>http://themelanomablog.com/blogs/2009/8/12/new-clinical-trial-open.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2009/8/12/new-clinical-trial-open.html"/><author><name>Dr Lynn Spitler</name></author><published>2009-08-12T17:15:39Z</published><updated>2009-08-12T17:15:39Z</updated></entry><entry><title>2009 AJCC/UICC Melanoma Staging System</title><id>http://themelanomablog.com/blogs/2009/5/23/2009-ajccuicc-melanoma-staging-system.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2009/5/23/2009-ajccuicc-melanoma-staging-system.html"/><author><name>Dr Lynn Spitler</name></author><published>2009-05-23T19:14:59Z</published><updated>2009-05-23T19:14:59Z</updated></entry><entry><title>Updated Melanoma Patient Web Resources &amp; Links 1.19.09</title><id>http://themelanomablog.com/blogs/2009/1/19/updated-melanoma-patient-web-resources-links-11909.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2009/1/19/updated-melanoma-patient-web-resources-links-11909.html"/><author><name>Dr Lynn Spitler</name></author><published>2009-01-20T00:19:26Z</published><updated>2009-01-20T00:19:26Z</updated></entry><entry><title>Report at 2008 ASCO Meeting Indicates Administration of Vaccine as Adjuvant Therapy of Melanoma Is Ineffective And May Be Harmful</title><id>http://themelanomablog.com/blogs/2008/8/10/report-at-2008-asco-meeting-indicates-administration-of-vacc.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2008/8/10/report-at-2008-asco-meeting-indicates-administration-of-vacc.html"/><author><name>Dr Lynn Spitler</name></author><published>2008-08-10T15:26:04Z</published><updated>2008-08-10T15:26:04Z</updated></entry><entry><title>Event: The Journey Through Cancer &amp; The Seven Levels of Healing</title><id>http://themelanomablog.com/blogs/2008/2/28/event-the-journey-through-cancer-the-seven-levels-of-healing.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2008/2/28/event-the-journey-through-cancer-the-seven-levels-of-healing.html"/><author><name>Dr Lynn Spitler</name></author><published>2008-02-28T06:29:54Z</published><updated>2008-02-28T06:29:54Z</updated></entry><entry><title>STILL ALIVE by HANK GARDSTEIN M.D.</title><id>http://themelanomablog.com/blogs/2007/8/29/still-alive-by-hank-gardstein-md.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2007/8/29/still-alive-by-hank-gardstein-md.html"/><author><name>Dr Lynn Spitler</name></author><published>2007-08-29T17:25:05Z</published><updated>2007-08-29T17:25:05Z</updated></entry><entry><title>2007 ASCO MEETING REPORT ON LONG-TERM ADJUVANT PEGYLATED INTERFERON-ALPHA2B</title><id>http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-long-term-adjuvant-pegylated-int.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-long-term-adjuvant-pegylated-int.html"/><author><name>Dr Lynn Spitler</name></author><published>2007-06-26T19:02:54Z</published><updated>2007-06-26T19:02:54Z</updated></entry><entry><title>2007 ASCO MEETING - REPORT ON IMMUNOLOGIC EFFECTS OF GM-CSF</title><id>http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-immunologic-effects-of-gm-csf.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2007/6/26/2007-asco-meeting-report-on-immunologic-effects-of-gm-csf.html"/><author><name>Dr Lynn Spitler</name></author><published>2007-06-26T18:32:43Z</published><updated>2007-06-26T18:32:43Z</updated></entry><entry><title>2007 ASCO MEETING SUMMARY</title><category term="Meetings"/><id>http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting-summary.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting-summary.html"/><author><name>Dr Lynn Spitler</name></author><published>2007-06-15T20:19:34Z</published><updated>2007-06-15T20:19:34Z</updated></entry><entry><title>2007 ASCO MEETING</title><id>http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting.html</id><link rel="alternate" type="text/html" href="http://themelanomablog.com/blogs/2007/6/15/2007-asco-meeting.html"/><author><name>Dr Lynn Spitler</name></author><published>2007-06-15T20:19:32Z</published><updated>2007-06-15T20:19:32Z</updated></entry></feed>